赛克林的sumoylation及其对癌症的治疗潜力
Hong-Yeoul Ryu1, Mark Hochstrasser2
1KNU G-LAMP Project Group, KNU Institute of Basic Sciences, School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, College of Natural Sciences, Kyungpook National University, Daegu, 41566, South Korea.
Animal cells and systems
|December 10, 2025
概括
基化精确调节细胞周期控制和预防癌症的关键环林D和E. 针对这种修改为与环林相关的恶性瘤提供了新的精准医学策略.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
- 生物化学 生物化学
背景情况:
- 细胞循环的进展依赖于循环素和循环素依赖激酶 (CDK) 的精确调节.
- 翻译后的修改,特别是化,越来越多地被认为是环林功能的关键调节者.
- 细胞循环的失调是癌症发展的一个基本方面.
研究的目的:
- 审查化在控制环林动态和细胞周期忠实性的作用.
- 探索异常的sumoylation在癌症进展中的影响.
- 讨论针对恶性瘤的SUMO途径的治疗潜力.
主要方法:
- 对近期关于苏莫ylation,环林和细胞循环调节的研究进行文献综述.
- 分析化对环林稳定性,局部化和活性的影响.
- 检查sumoylation,环林失调和瘤发生之间的联系.
主要成果:
- 基化极大地影响了循环素D和E的稳定性,局部化和活性,这对于G1/S过渡至关重要.
- 异常的循环的相约化可以增强它们的致癌潜力,有助于癌症的进展.
- SUMO途径代表了治疗林相关癌症的治疗干预的有希望的目标.
结论:
- 基化是循环蛋白功能的关键调节剂,维持细胞分裂的忠实性.
- 向sumoylation通路为瘤学中的精密医学提供了新的治疗策略.
- 进一步了解sumoylation在循环调节中的作用可能会彻底改变循环依赖疾病的治疗方法.
相关概念视频
Positive Regulator Molecules
6.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K
Positive Regulator Molecules
133.8K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
133.8K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
M-Cdk Drives Transition Into Mitosis
6.2K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K


